BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 8, 2011
View Archived Issues
Novel phosphodiesterase 10A inhibitors synthesized
Read More
Lotus Tissue Repair raises funds to advance treatment for dystrophic epidermolysis bullosa
Read More
Johns Hopkins University and Innogene Kalbiotech begin trial for lung cancer vaccine
Read More
ISC-4 exhibits safety and antitumor activity in murine model of human colon cancer
Read More
Preclinical study supports further evaluation of dovitinib in Waldenstrom's macroglobulinemia
Read More
Leukothera shows synergistic activity with chemotherapeutic agents in leukemia cell lines
Read More
New lysophospholipid S1P1 receptor agonists presented by Almirall
Read More
Roche discloses new glycogen synthase activators
Read More
Bristol-Myers Squibb and Innate Pharma enter global agreement for IPH-2102
Read More
INV-144 enters phase IIa trial to slow kidney disease in patients with hypertension and diabetes
Read More
Novel nuclear receptor related 1 receptor ligands patented by Sanofi
Read More
Novel PI3K inhibitors prepared
Read More
Dainippon Sumitomo and AstraZeneca claim new Toll-like receptor modulators
Read More
Vantia Therapeutics raises funds to develop VA-106483 and VA-111913
Read More
Roche discloses novel series of monoamine reuptake inhibitors
Read More
Dual mTORC1/mTORC2 inhibition may enhance treatment of acute myeloid leukemia
Read More
Metabolic Solutions receives funds from the Alzheimer's Drug Discovery Foundation
Read More
Zafgen secures financing for phase II trial in obesity
Read More
INNO-206 shows safety in ongoing phase Ib trial in soft tissue sarcoma
Read More
IDMC recommmends continuation of phase III VENICE trial of Zaltrap in advanced prostate cancer
Read More
Merck KGaA to discontinue development of Toll-like receptor 9 agonist IMO-2055
Read More
Amylin Pharmaceuticals, Lilly and Alkermes report on tQT study of Bydureon
Read More
Phase III EXIST-1 trial of Afinitor in tuberous sclerosis meets primary endpoint
Read More
TMC-435 receives FDA fast track status in chronic hepatitis C genotype 1
Read More
Amsterdam Molecular Therapeutics requests reexamination of MAA for gene therapy Glybera
Read More